جستجوی استاد راهنمای دانشگاهی

Professor Maria Craig is a distinguished academic and researcher at the University of New South Wales, Faculty of Medicine & Health, specializing in childhood diabetes research. She holds a prominent position as a Professor with extensive contributions to the field of pediatric endocrinology and diabetes, particularly focusing on type 1 diabetes in children. Professor Craig's educational background includes: MB BS from the University of Melbourne MMedSc(ClinEpid) from the University of Newcastle PhD from the University of Sydney FRACP (Fellow of the Royal Australasian College of Physicians) Professor Craig's research primarily focuses on childhood diabetes, with special emphasis on prediction and prevention of type 1 diabetes. She has a significant interest in the association between viruses and type 1 diabetes, collaborating with the Virology Research Group at Prince of Wales Hospital (POWH). Together with Professor Bill Rawlinson, she leads the viral theme for the multicentre ENDIA study (endia.org.au). As principal investigator for the CoRD trial, she is conducting a world-first phase 1 study using autologous cord blood for prevention of type 1 diabetes in children with islet autoimmunity. Additionally, she serves as principal investigator for the Australasian Diabetes Data Network (ADDN). Her research portfolio also encompasses the epidemiology of various forms of childhood diabetes (type 1, type 2, cystic fibrosis related diabetes and monogenic diabetes) and diabetes complications, in collaboration with Professor Kim Donaghue at the Children's Hospital at Westmead. Professor Craig's extensive publication record, including over 361 journal articles, demonstrates her leadership in advancing our understanding of childhood diabetes. Her recent work shows increasing focus on early detection methods, risk prediction models, technological interventions for diabetes management, and the complex interplay between viral infections and autoimmune diabetes development. She has been instrumental in developing clinical practice guidelines through her role as co-editor of the International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines. Professor Craig has received numerous prestigious awards recognizing her contributions to pediatric endocrinology and diabetes research: Australian Paediatric Endocrine Group Young Investigator's Award (1997) Asia Pacific Paediatric Endocrine Society Clinical Teaching Award (2008) Lifetime Honorary Member, Caring and Living as Neighbours (2013) Australian Diabetes Society Jeff Flack Diabetes Data Award (2019) Australian Paediatric Endocrine Group Norman Wettenhall Award for Research and Innovation (2019) Throughout her career, Professor Craig has demonstrated exceptional leadership in professional societies, having served as former president/treasurer of the Australasian Paediatric Endocrine Group (APEG) and currently as Scientific Convenor of the Asia Pacific Paediatric Endocrine Society Fellows school. Her work with the ENDIA study and Australasian Diabetes Data Network represents significant collaborative research efforts involving multiple institutions across Australia and internationally. Her principal investigator roles for major studies indicate substantial research funding support. Professor Craig leads several important research initiatives including the ENDIA study, the CoRD trial, and the Australasian Diabetes Data Network. These programs involve multidisciplinary teams of researchers, clinicians, and support staff working collaboratively to advance understanding and treatment of childhood diabetes. Her work at the intersection of virology and diabetes represents a unique and innovative approach to understanding the environmental triggers of type 1 diabetes.

• Childhood Diabetes
• Type 1 Diabetes
• Virology and Diabetes
• +۴ مورد دیگر

Dr. Jose Perdomo is a Research Fellow at the Central Clinical School, Sydney Medical School, within the Faculty of Medicine and Health at the University of Sydney. He is based at the Charles Perkins Centre, where his research focuses on endothelial damage, immune complex-driven thrombosis, and platelet formation mechanisms. His work employs techniques such as flow cytometry, microfluidics, and intravital microscopy. Dr. Perdomo holds a PhD from the University of Sydney’s School of Molecular and Microbial Biosciences and received a Vice-Chancellor’s Fellowship. His research has led to two international patents and recognition, including 1st prize in the 2020 China Shenzhen Innovation Competition. His studies explore targeted inhibitors to prevent immune complex formation and thrombosis, with applications in cardiovascular health. His research interests include the interplay between white blood cells, endothelial cells, and platelets, with a focus on desialylation, apoptosis, and NETosis in immune thrombocytopenia. He has contributed to understanding vaccine-induced immune thrombocytopenia and thrombotic complications post-myocardial infarction. His findings have been featured in Nature Communications , Blood Advances , and other high-impact journals. Awards: 1st prize in China Shenzhen Innovation Competition (2020). Labs/Teams: Charles Perkins Centre, University of Sydney. Grants: Vice-Chancellor’s Fellowship (University of Sydney). Media Contributions: Insights into AstraZeneca vaccine-related blood clots featured in The Guardian , SMH , and ABC News.

• Thrombosis
• Hematology
• Immunology
• +۳ مورد دیگر

Gabriela Minigo serves as an Honorary Fellow in Global and Tropical Health and Associate Dean - Learning and Teaching within the Faculty of Health. Her academic profile demonstrates active engagement in malaria immunology research with a recent expansion into circadian rhythm and metabolic health investigations. Dr. Minigo completed her PhD at the University of Melbourne (awarded March 31, 2007) and earned a Master of Clinical Epidemiology from the University of Newcastle (awarded December 8, 2017). Her educational background provides a strong foundation in both basic science and clinical epidemiology. Her primary research focuses on immunological responses to malaria, with particular expertise in T follicular helper cells, dendritic cell function, and regulatory T cells in Plasmodium falciparum and Plasmodium vivax infections. Analysis of her research fingerprint reveals significant contributions to Plasmodium falciparum Immunology and Microbiology (100%), Dendritic Cell Immunology and Microbiology (45%), Regulatory T Cell Immunology and Microbiology (38%), and other related fields. In recent years, she has expanded her research to investigate the relationship between photoperiod, circadian rhythm, and metabolic health, as evidenced by her 2024 publications on these topics. Dr. Minigo's scholarly output shows an evolving research trajectory from fundamental malaria immunology toward interdisciplinary investigations connecting circadian biology with metabolic health. Her recent publications (2022-2024) demonstrate continued strong contributions to malaria immunology while incorporating new dimensions related to light exposure, sleep patterns, and glucose control. She has secured research funding for multiple projects including 'Rainmaker start up- Does exposure to artificial light alter circadian rhythm and glucose control in Australian adults? A pilot study' (2023-2026) where she serves as Co-Investigator, and 'Effect of Extended Photoperiod Exposure on Circadian Rhythm and Glucose Control' (2024-present) where she is Principal Investigator. Previously, she contributed as Chief Investigator C to 'Manipulating T follicular helper cells to improve human malaria vaccines' (2020-2023). As Associate Dean for Learning and Teaching, Dr. Minigo holds significant educational leadership responsibilities within the Faculty of Health. She is registered to supervise postgraduate research, indicating her active role in mentoring graduate students in immunology and tropical medicine research.

• Immunology
• Microbiology
• Malaria Research
• +۵ مورد دیگر

Dr. Holger Scheib is an Honorary Associate Professor in the School of the Environment at The University of Queensland. His research focuses on venom evolution, toxinology, and biomedical applications, particularly in reptiles, cnidarians, and other venomous organisms. He collaborates extensively with international researchers on projects involving venom structure-function relationships, evolutionary biology, and clinical implications of venom variation. Research interests span venom evolution, toxin structure and function, and their applications in biomedical contexts. He investigates venom diversity across species, including reptiles, sea anemones, and cnidarians, focusing on how these toxins interact with biological systems. His work also explores the intersection of venom components with allergens and their structural similarities, contributing to a deeper understanding of venom’s ecological and medical significance. His recent publications highlight advancements in understanding venom evolution, toxin structures, and clinical implications. Studies include comparisons of venom proteins with allergens, analyses of venom variation in rattlesnakes, and investigations into the molecular mechanisms of bacterial secretion systems. These works contribute to both basic biological research and potential applications in medicine and biodiscovery. No scientific awards or grants are explicitly mentioned in the provided text. Dr. Scheib’s research is primarily conducted through collaborations within the School of the Environment and international academic networks. No specific lab or team affiliations are detailed.

• Venom Research
• Toxinology
• Biomedical Research
• +۳ مورد دیگر

Claire O'Brien is an Associate Professor in Biomedical Science (Virology) at the University of Canberra, leading the Host-Microbe Interactions research group. Previously, she held positions at the Australian National University (ANU) Medical School as a Lecturer and Senior Lecturer at the University of Wollongong. She earned her PhD from ANU in 2012, focusing on microbiological aspects of Crohn's disease. Her research investigates gut microbiome dysbiosis in diseases like inflammatory bowel disease (IBD), using in vitro co-cultures of bacteria and macrophages. Key projects include studying antimicrobial resistance in retail meat and microbial resilience in IBD patients. Dr. O'Brien has received prestigious awards, including the Australian Academy of Science France-Australia Fellowship and NHMRC Peter Doherty Biomedical Research Fellowship. Her work spans translational research, such as the 'GUTSY' project addressing sarcopenia in Crohn’s disease, and collaborations on microbiome dynamics. She actively supervises Honours and higher-degree research students in IBD and microbiome-related fields. Research interests include host-microbe interactions, Crohn's disease pathogenesis, and the role of the microbiome in health. Her lab employs genomic, transcriptomic, and microbiological techniques to uncover mechanisms linking microbial imbalances to disease. She is also engaged in public health initiatives, such as optimizing preconception care and reducing pregnancy complications in women with polycystic ovary syndrome (PCOS).

• Inflammatory Bowel Disease
• Gut Microbiome
• Host-Microbe Interactions
• +۳ مورد دیگر

Andrew Currie is a Professor and Associate Dean (Research & Innovation) at Murdoch University's School of Medical, Molecular and Forensic Sciences, within the College of Environmental and Life Sciences. He leads the Sepsis Diagnostics Research Group at the Centre for Molecular Medicine and Innovative Therapeutics and co-heads the Neonatal Infection and Immunity Team with Clinical Professor Tobias Strunk at the Wesfarmers Centre of Vaccine & Infectious Diseases at Telethon Kids Institute. His research focuses on immunology and infectious diseases in pediatric populations, particularly sepsis diagnostics and neonatal immunity. Education: PhD (Immunology, University of Western Australia, 2001); BSc (Biotechnology with Honors, Murdoch University, 1997). Research Interests: Sepsis diagnostics, innate immunity mechanisms in neonates, medical biotechnology for diagnostics (e.g., biosensors), and translational research in pediatric infections. Collaborates internationally with institutions in Canada, Denmark, the UK, US, and China. Aims to reduce sepsis burden in vulnerable populations through advanced molecular methods and interdisciplinary partnerships. Key Affiliations: Lead of Sepsis Diagnostics Research Group (Murdoch University), Senior Lecturer in Immunology, Honorary Associate at Kids Research Institute Australia. Past roles include leadership in the Centre for Molecular Medicine and Innovative Therapeutics. Scientific Contributions: Over 100 peer-reviewed articles focusing on sepsis biomarkers, neonatal immunity, tick-borne diseases, and clinical trials for interventions like vitamin C and probiotics in critical illness. Active in developing precision medicine approaches for neonatal sepsis. Grants & Funding: Co-leads major projects on sepsis diagnostics and neonatal infection, supported by national and international grants. Collaborates on multi-institutional initiatives. Labs/Teams: Sepsis Diagnostics Research Group (Murdoch) and Neonatal Infection and Immunity Team (Telethon Kids Institute). Works closely with the Personalised Medicine Centre and Health Futures Institute.

• Sepsis
• Innate Immunity
• Neonatal Immunology
• +۵ مورد دیگر

Dr. Maryam Roudbary is an Adjunct Senior Lecturer at the Westmead Clinical School, part of the Sydney Medical School, University of Sydney. She joined the Sydney Infectious Diseases Institute (Sydney ID) in 2023 as a researcher affiliated with the University of Sydney and employed by NSW Health and Research Network as a Senior Researcher in Mycology. Previously, she served as an Associate Professor at Iran University of Medical Sciences (2015–2022), leading research projects and supervising Master’s and PhD students in medical mycology and fungal infections. Her PhD in Medical Mycology focused on antifungal resistance mechanisms and new therapeutic strategies. Current research priorities include developing novel antifungal agents against drug-resistant fungi, understanding resistance mechanisms, and addressing challenges outlined in the WHO’s 2022 Fungal Priority Pathogen List. She is an editor for several mycology journals and co-authored The Book of Fungal Pathogens (2022). Roudbary’s work spans epidemiological studies, clinical sampling, and collaborations in One Health AMR initiatives. She leads projects on fungal diversity exploration (e.g., Vietnam citizen science initiatives) and evaluates natural compounds (e.g., thymus extracts, nanoparticles) for antifungal efficacy. Recent grants include a 2025 project on antifungal peptide-based therapeutics. Her research emphasizes biofilm formation in filamentous fungi, Candida species pathogenesis, and fungal co-infections in immunocompromised patients, including those with severe COVID-19. Key findings include the prevalence of azole-resistant Candida species in Iran and the role of gene expression (e.g., CDR1 , HWP1 ) in drug resistance. Roudbary’s contributions include over 100 peer-reviewed articles, grants focusing on antifungal innovation, and active roles in international mycology networks. She bridges clinical and research domains through translational studies targeting critical fungal health challenges.

• Medical Mycology
• Antimicrobial Resistance
• Infectious Diseases
• +۴ مورد دیگر

Prof Justin Seymour is a Professor in the Climate Change Cluster (C3) at the University of Technology Sydney (UTS). He leads the Ocean Microbiology Group, focusing on microbial ecology and oceanography. His research explores microbial roles in ocean ecosystems, spanning from ocean-basin dynamics to microscale interactions between microbes and marine organisms. He supervises Masters and PhD students, teaches Microbial Ecology (91170), and advises on courses like Ocean Systems and Climate Change (91156). Education: Not explicitly listed, but his academic role implies advanced degrees in microbiology or marine science. Affiliations: Faculty of Science, UTS Climate Change Cluster (C3) Research Interests: His work addresses microbial contributions to ocean biogeochemistry, including interactions between microbes and corals, fish, seagrasses, and harmful pathogens. Key themes include: Microbial Oceanography Marine Microbial Ecology Climate Change Impacts on Microbiomes Articles Trends: Recent publications emphasize climate-driven shifts in microbial communities, pathogen dynamics linked to oyster mortality, and chemotaxis mechanisms in marine bacteria. Research highlights include the role of Vibrio species in disease outbreaks and the influence of marine heatwaves on microbiology. Awards: ARC Discovery Projects (DP240100370, DP230100127, DP210101610) UTS Chancellor's Research Fellowship Gordon and Betty Moore Foundation Grant Advising & Grants: Active in securing funding (e.g., ARC, NSW Government, Fisheries grants) for projects like oyster disease resilience and microbial contamination studies. Supervises interdisciplinary teams addressing climate change and marine health challenges. Labs/Teams: Leads the Ocean Microbiology Group, collaborating internationally on microbial ecology, coral restoration, and aquaculture.

• Aquatic Microbial Ecology
• Biological Oceanography
• Marine Microbial Interactions
• +۳ مورد دیگر

Professor Ruth Zadoks is a faculty member at the Sydney School of Veterinary Science, University of Sydney. She holds academic positions in the Sydney Institute of Agriculture and Sydney Southeast Asia Centre, and is involved with the Sydney Infectious Diseases Institute. Her research focuses on antimicrobial resistance, zoonotic diseases, bovine health, and One Health principles. Notable projects include investigations into Japanese encephalitis transmission dynamics, antibiotic use in East African livestock, and molecular epidemiology of Group B Streptococcus. Recent grants include studies on microbial spillover in aquaculture and precision feeding in broiler chickens. Her work integrates veterinary and public health perspectives, addressing issues like anthrax impacts in rural Africa, tilapia-borne zoonoses, and diagnostic innovations for bovine mastitis. Over 118 peer-reviewed publications highlight her contributions to aquatic pathogen genomics, food safety, and livestock disease ecology. Recent grants (2024): - Revealing microbial spillover drivers in aquaculture (SSEAC Incubator) - Sustainable Precision Feeding in Broiler Chickens (AgriFutures) - ASEAN Antimicrobial Resistance Network (DFAT-funded) Labs/Teams: Affiliated with Sydney Infectious Diseases Institute and collaborates across interdisciplinary One Health networks.

• Veterinary Epidemiology
• Antimicrobial Resistance
• One Health
• +۳ مورد دیگر

Dr. Deirdre Collins is an NHMRC Early Career Fellow at Edith Cowan University (ECU), affiliated with the School of Medical and Health Sciences. She collaborates with Professor Thomas Riley's research group at PathWest Laboratory Medicine, QEII Medical Centre. Her primary focus is Clostridium difficile infection epidemiology, molecular diagnostics, and antimicrobial resistance. Dr. Collins holds a PhD from the University of Western Australia (2017) and a Master of Infectious Diseases (2011). Research Interests: Clostridium difficile infection, infectious disease epidemiology, molecular epidemiology, One Health, antimicrobial resistance. Key Projects: Includes a One Health/System Dynamics approach to reducing C. difficile infections (NHMRC Ideas Grant 2022–2025) and studies on environmental sources of C. difficile in hospitals. Her research spans Asia-Pacific regions, emphasizing community and hospital-acquired infections. Notable achievements include: Published over 50 peer-reviewed articles on C. difficile genomics, transmission dynamics, and environmental contamination. Received awards such as the Australasian Epidemiological Association Travel Award (2018) and Vice-Chancellor's Excellence in Research Award (2018). Active in grants totaling over $2M, including NHMRC Early Career Fellowship (2019–2023). Dr. Collins' work bridges laboratory research and public health policy, addressing global health challenges through interdisciplinary collaboration.

• Clostridium difficile Infection
• Infectious Disease Epidemiology
• Molecular Epidemiology
• +۳ مورد دیگر

Dr. Bei Bei is an Associate Professor at the School of Psychological Sciences, Monash University, and an NHMRC Emerging Leadership (EL2) Fellow. She leads the Behavioural Sleep Medicine service, research, and training at Monash University Healthy Sleep Clinic, focusing on individual differences in sleep-wake behaviors, sleep-mental health relationships, and community dissemination of evidence-based sleep interventions. Doctor of Psychology (Clinical), University of Melbourne PhD, University of Melbourne Her research spans six major areas: Sleep-wake circadian rhythm disorders Cognitive Behavioral Therapy for Insomnia (CBT-I) Psychological/behavioral aspects of sleep Sleep-mental health interactions (mood, anxiety) Adolescent sleep patterns and wellbeing Perinatal/postpartum sleep interventions for women Recent publications (2024-2025) address: Insomnia treatment mechanisms in depression comorbidity Neurodevelopmental impacts of circadian factors Pregnancy-related insomnia risk identification Adolescent sleep facilitators/barriers Integrated models for youth depression and sleep across continents She also contributes to: Antifungal drug tolerance mechanisms RNA polyadenylation dynamics Mitochondrial RNA stability in cancer 3' UTR splice variants in rare diseases Awarded the NHMRC Emerging Leadership (EL2) Fellowship and Early Career Research Grant , Dr. Bei serves on editorial boards for Sleep Medicine Reviews, Sleep, and Behavioral Sleep Medicine journals.

• Sleep Disorders
• Circadian Rhythm
• Clinical Psychology
• +۵ مورد دیگر

Dr. Kim O'Sullivan is a Senior Research Fellow and head of the Translational Kidney Therapies Group at the Centre for Inflammatory Diseases (CID), Monash Health Translational Precinct, affiliated with Monash University’s Faculty of Medicine, Nursing and Health Sciences. She holds a PhD in Immunology from Monash University and completed her undergraduate and Master’s studies in Anatomy and Structural Biology at the University of Otago, New Zealand. Her work is centered on developing novel therapies for autoimmune kidney diseases, particularly ANCA-associated vasculitis (AAV), glomerulonephritis, and lupus nephritis. Her research focuses on: Neutrophil Extracellular Traps (NETs) and their role in inflammation Gene therapy using adeno-associated viral vectors to deliver DNase I Therapeutic potential of bacterial exosomes Gut microbiome interactions, especially Muribaculaceae and SCFAs Immune tolerance and host defense preservation Her recent publications (2023–2024) reflect a strong trend in translational immunology, with emphasis on microbiome-immune crosstalk, novel biologics, and gene-based interventions. She has published in high-impact journals such as Frontiers in Immunology , International Journal of Molecular Sciences , and Journal of Immunology . Her scientific contributions have been recognized through several awards: Australian and New Zealand Society of Nephrology Young Investigator Award (Winner, 2016) ANZSN Basic Science Award (Finalist, 2020) Multiple ANZSN Travel Awards (2014, 2016, 2017) Kim O'Sullivan actively supervises Honours and PhD students and leads multiple research projects funded by NHMRC and MRFF. She serves on the ANZSN Scientific Programme and Awards Committee (SPARC), is a Review Editor for Frontiers in Immunology , and sits on the editorial boards of International Journal of Molecular Sciences and Journal of Integrated Medicine in Nephrology and Andrology . She is also a peer reviewer for top journals including Journal of Clinical Investigation and Kidney International . She leads the CID weekly seminar series and chaired the ImmuMON21 symposium. Her commitment to equity in STEM includes mentoring through BrainSTEM and past involvement in the ANZSN Equity, Diversity and Inclusion Committee.

• Immunology
• Autoimmune Diseases
• Kidney Disease
• +۱۳ مورد دیگر

Professor James St John is a translational neuroscientist and HTH Dean (Research) at Griffith University, leading the Clem Jones Centre for Neurobiology and Stem Cell Research. His work focuses on developing cell-based therapies for spinal cord injury, leveraging olfactory glial cells and three-dimensional nerve bridges. He holds a PhD in Agricultural Science from the University of Melbourne and has secured over $35 million in research funding. Affiliations: Institute for Biomedicine and Glycomics, Griffith University Roles: Professor, Head of Clem Jones Centre, HTH Dean (Research) Research interests include spinal cord injury repair, peripheral nerve regeneration, microbial contributions to neurodegeneration, and olfactory system biology. His team is advancing a Phase I/IIA clinical trial for spinal cord injury therapy using autologous olfactory cell transplantation combined with rehabilitation. Key grants include Perry Cross Spinal Research Foundation funding ($5M+), NHMRC/MRFF support, and philanthropic donations from the Clem Jones Foundation. Supervised over 30 doctoral and master’s students in neural repair research. Labs/Teams: Clem Jones Centre for Neurobiology and Stem Cell Research, collaborating with Making Strides Rehabilitation for clinical trial readiness.

• Spinal Cord Injury Repair
• Peripheral Nerve Injury
• Neurodegeneration
• +۴ مورد دیگر

Dr. Peter Zilm is an Associate Professor in the Adelaide Dental School at the University of Adelaide, part of the Faculty of Health and Medical Sciences. His research focuses on bacterial biofilm dynamics, particularly in oral pathogens linked to caries and periodontal disease, and their systemic implications. Key projects include developing oral microbiome transplantation therapies and pH-responsive 'intelligent particles' as antimicrobial agents. Collaborations with chemical engineers and industry aim to advance nano-technological solutions for dental applications. Research interests span biofilm inhibition mechanisms, the gut microbiome's role in gastrointestinal inflammation triggered by periodontitis, and the development of novel antimicrobial coatings for medical devices. His work integrates advanced technologies like cellular impedance (exCELLigence) and next-generation sequencing. He has secured NHMRC funding (2020-25) for oral microbiome transplantation research. Projects are based at the Helen Mayo South Building and involve collaborations with institutions in Spain, the UK, and elsewhere. Dr. Zilm supervises Honours, Masters, and PhD students across multiple translational projects, including anti-biofilm agents, oral microbiome transplantation efficacy, and the relationship between oral bacteria and systemic diseases like cardiovascular issues and cancer. His recent publications highlight innovations in nano-technology, biofilm disruption, and probiotic interventions for periodontal disease.

• Oral Microbiology
• Biofilm Biology
• Antimicrobial Nano-Technology
• +۴ مورد دیگر

Dr. Ian Peak is a Senior Lecturer in Microbiology and Infectious Diseases at Griffith University's School of Pharmacy and Medical Sciences. His research investigates bacterial surface carbohydrate structures and their roles in pathogenesis, focusing on pathogens causing otitis media and respiratory infections. He serves as Program Director for the Bachelor of Health Science. Qualifications include a PhD in Social Policy (University of Bath), MBA in Senior Leadership, and degrees in law and medical ethics. His research examines microbial glycobiology to identify vaccine targets against otitis media pathogens, particularly Moraxella species. Current investigations focus on polysaccharide structures from Moraxella strains and their immunogenic potential. Recent publications analyze capsular polysaccharides from Moraxella species, lipooligosaccharide biosynthesis genes, and advances in otitis media vaccine development. His work integrates structural biology with immunological evaluation of potential vaccine candidates. Dr. Peak leads doctoral projects on structural characterization of Moraxella surface molecules and vaccine development for childhood ear infections. His research contributes to understanding bacterial adaptation mechanisms and developing interventions against antibiotic-resistant infections.

• Microbial Pathogenesis
• Bacterial Glycobiology
• Vaccine Development
• +۳ مورد دیگر